Global Market Size, Forecast, and Trend Highlights Over 2025-2037
Impingement Syndrome Market size was valued at USD 1.6 billion in 2024 and is anticipated to surpass USD 3.7 billion by 2037, registering a CAGR of 7.3% during the forecast timeline i.e. 2025-2037. In 2025, the industry size of impingement syndrome is evaluated at USD 1.7 billion.
The impingement syndrome market is experiencing noteworthy growth due to the increasing prevalence of musculoskeletal disease. For instance, in July 2022, as per the data revealed by the WHO, around 1.71 billion people worldwide suffered from musculoskeletal disorders. Furthermore, the increased activity of recreation and work at the workplace continuously stresses the glenohumeral joint. For instance, in August 2023, according to the National Library of Medicine, an estimated 17 out of 100,000 people experience glenohumeral joint dislocation annually, with males aged 21 to 30 and females aged 61 to 80 experiencing the highest incidence.
Moreover, the current trends acknowledge the minimally invasive intervention and nonoperative management, enhancing the growth of physical therapy services, orthobiologic therapy, and high-tech imaging modalities. For instance, in June 2023, using its patented CITREGEN biomaterial technology, Acuitive Technologies, Inc. announced that the FDA has granted them 510(k) clearance to market CITREGRAFT, a novel synthetic bioactive bone void filler. In addition, increasing focus on preventive strategies, such as ergonomic analysis and tailored exercise regimens, is driving occupational health, thus sustaining overall market growth momentum.
Impingement Syndrome Sector: Growth Drivers and Challenges
Growth Drivers
- Surging instances related to sports injuries: Greater numbers of sports injury cases are a key driver of growth for the impingement syndrome market. For instance, the 2025 National Safety Council report stated that sports and recreational injuries rose 20% in 2021, 12% in 2022, and 2% in 2023 as compared to the statistics of 2020. In addition to this, nonetheless, there were an estimated 5,228,791 injuries nationwide as of June 2023, as per the June 2023 American Academy of Orthopaedic Surgeons report. With increased participation in sporting activities across different age groups, repetitive overhead activity, and acute trauma being involved in most sporting activities, it spurs the market growth.
- Advancement in surgical techniques: The inclination and adoption towards minimally invasive surgical procedures, i.e., arthroscopic surgery, is fueling the growth of the impingement syndrome market to a great extent. For instance, in January 2024, TheNanoExperience.com, a new patient-focused resource from Arthrex, was launched. It highlighted the science and advantages of Nano arthroscopy, which is a cutting-edge, least-invasive orthopedic procedure. These new technologies represent incisions and better visualization, that have lowered recovery time for patients. Therefore, patient demand for these minimally invasive procedures translates into direct demand for surgery and thus widens the market.
Challenges
- Variability in treatment effectiveness: Treatment heterogeneity is among the biggest issues that the impingement syndrome market faces. Surgery in the form of subacromial decompression also gives results of a varying nature based on patient anatomy, surgical proficiency, and postoperative rehabilitation. This uncertainty in the response to treatment is the necessity for customized treatment protocols, ruling out the application of blanket regiments and the guarantee for both patient and clinician to rely on established parameters.
- Healthcare costs and reimbursements: Compensation and healthcare expenses are colossal obstacles in the impingement syndrome market. The spectrum of the diagnostic process in the clinical test, imaging studies, and even potentially the diagnostic injection creates a cost skyrocketing. It is further characterized by regular visits, at a predictable price. Moreover, reimbursement policy for non-operative therapy is very diverse, resulting in patient access and physician reimbursement disparities. In addition, the variation in surgical intervention cost depending on the insurance company's policy as well as local health system conditions brings economic uncertainty to both the patient and the healthcare provider.
Impingement Syndrome Market: Key Insights
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
7.3% |
|
Base Year Market Size (2024) |
USD 1.6 billion |
|
Forecast Year Market Size (2037) |
USD 3.7 billion |
|
Regional Scope |
|
Impingement Syndrome Segmentation
Type (Primary Impingement Syndrome, Secondary Impingement Syndrome)
Primary impingement syndrome segment is poised to account for impingement syndrome market share of more than 57.2% by the end of 2037. It results from intrinsic structural defects, causing direct irritation of the tendons of the rotator cuff. Such underlying anatomical positions, in many cases coupled with the processes of aging, have a high rate of occurrence with the resultant formation of primary impingement signs. For instance, in January 2022, a team of researchers at Harvard’s Wyss Institute for Biologically Inspired Engineering collaborated with Novartis Technical Research and Development, to develop Janus Tough Adhesives (JTA’s). It is a biomaterial-based adhesive that facilitates faster healing in long-standing tendon bone injuries.
Patient Age Group (Pediatric (children and adolescents), Adult (18-65 years), and Geriatric (65+ years))
Based on the patient age group, the geriatric population is anticipated to garner a major share in the impingement syndrome market during the stipulated timeframe. This growth is attributed to the rising incidences amongst this population group, as such a group is prone to the diseases. For instance, in December 2023, according to the UNFPA statistics, by 2050, there will be an astounding 347 million elderly people (those 60 and older), up from 153 million in 2023. Moreover, the emerging popularity of the minimally invasive arthroscopic technique, commonly known as shoulder arthroscopy, which relies on very small incisions to preserve joint mobility and function, is also bolstering market growth.
Our in-depth analysis of the global market includes the following segments:
|
Type |
|
|
Impingement Site |
|
|
Patient Age Group |
|
|
Treatment Type |
|
Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.
Customize this ReportImpingement Syndrome Industry - Regional Synopsis
North America Market Statistics
North America impingement syndrome market is set to hold revenue share of over 41.3% by the end of 2037. Its well-developed healthcare infrastructure and sports injury rate spur the demand in the market. Furthermore, it facilitates early diagnosis and the availability of advanced treatment modalities. In addition, the region's rapid lifestyle with high participation rates in sports and physical exercises offers a wide patient pool of impingement syndrome.
The U.S. impingement syndrome market is exponentially growing, fueled by the availability of easy diagnosis via cutting-edge imaging and access to a wide variety of treatment options. For instance, in December 2024, Axial3D announced a formal partnership with GE HealthCare, aiming at a significant step forward in the development of 3D patient-specific models using MR imaging. Through this partnership, clients have access to a new suite of sophisticated 3D modeling services by combining Axial3D's AI-powered segmentation platform, Axial3D INSIGHTTM, with GE HealthCare's distinctive oZTEo bone imaging application.
The Canada impingement syndrome market is experiencing remarkable growth during the projected timeframe. Canada's market for impingement syndrome is well established, courtesy of its nationalized healthcare. For instance, in February 2025, a significant turning point in Contura Orthopedics' international growth has attained with the announcement of Contura Orthopedics (Canada) Ltd. After Arthrosamid was approved by Health Canada in 2024, making this innovative hydrogel injection accessible to patients with osteoarthritis (OA)-related knee pain has revolutionized the market.
Asia Pacific Market Analysis
The Asia Pacific impingement syndrome market is growing at a remarkable pace due to the demand for diagnostic equipment. In addition, the market has grown as a result of government research and development programs and rising healthcare costs. Furthermore, the changing lifestyles, an aging population, and an increase in the prevalence of orthopedic diseases, all cater to market flourishment in the projected timeline.
The India impingement syndrome market is experiencing a phenomenal growth trend, driven chiefly by the increasing availability of orthopedic centers, expanding healthcare expenditures, and financial and regulatory aid by the government. For instance, in January 2025, the IBEF updated that according to the Economic Survey 2023-24, India's public spending on healthcare reached 1.9% of GDP in FY24, up from 1.6% in FY23. By FY25 and is projected to reach 2.5%. In addition, in the first five months of 2024, private equity and venture capital investments topped USD 1 billion, a 220% increase from the year before.
China impingement syndrome market is demonstrating remarkable growth, mainly due to the accelerated expansion of its health centers and urbanization. For instance, in January 2025, Siemens Shenzhen Magnetic Resonance Ltd. celebrated a major milestone and strengthened its position through introducing a new facility expansion. Through the cutting-edge facility, with 63,000 square meters of land having a floor area of 98,000 square meters with an investment of USD136 million.
Companies Dominating the Impingement Syndrome Landscape
- Medtronic plc
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Johnson & Johnson
- Breg, Inc.
- CONMED Corporation
- Ossur hf.
- Colfax
- Globus Medical, Inc.
- Wright Medical Group N.V.
- Arthrex, Inc.
- Orthofix Medical Inc.
- Bioventus LLC
The competition within the impingement syndrome market is controlled by minimally invasive surgical techniques and the development of advanced pain therapy treatments. For instance, December 2023, AdvaMed announced the creation of a new medical imaging technology division intending to represent both big and small businesses in promoting the advanced medical imaging, radiopharmaceuticals, medical imaging technology, and focused ultrasound devices. This emphasis implies that firms can differentiate themselves by offering better quality clinical results and reduced recovery times for patients, and in doing so gain a competitive edge in a growing market.
Here's the list of some key players:
In the News
- In November 2024, Johnson & Johnson MedTech and Responsive Arthroscopy Inc., announced an exclusive commercial distribution agreement in the U.S. This strategic partnership enhanced Johnson & Johnson MedTech's sports platform and broadens its soft tissue portfolio to meet the increasing demand for innovative solutions.
- In November 2023, Pristine Surgical accelerated for release the first-of-its-kind SummitTM 4K. It is a fully-integrated single-use scope that simplifies arthroscopic procedures with minimally invasive visualization technology into a sterile, cost-effective, ready-to-use package.
Author Credits: Radhika Pawar
- Report ID: 7271
- Published Date: Mar 05, 2025
- Report Format: PDF, PPT
